Tectonic Therapeutic, Inc. (TECX) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TECX Revenue Growth
TECX Revenue Analysis (2016–2025)
As of May 8, 2026, Tectonic Therapeutic, Inc. (TECX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, TECX's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including RCUS (+67.4% YoY), ARQT (+95.3% YoY), and KYMR (-12.6% YoY). Compare TECX vs RCUS →
TECX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TECXCurrent | $0 | - | - | - | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% |
TECX Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-84,036,000 | - |
| 2024 | $0 | - | $0 | - | $-58,015,000 | - |
| 2023 | $0 | - | $0 | - | $-44,648,000 | - |
| 2022 | $0 | - | $0 | - | $-32,830,000 | - |
| 2021 | $0 | - | $0 | - | $-15,610,000 | - |
| 2020 | $0 | - | $-1,207,000 | - | $-120,228,000 | - |
| 2019 | $0 | - | $-850,000 | - | $-75,809,000 | - |
| 2018 | $0 | - | $-380,000 | - | $-46,243,000 | - |
| 2017 | $0 | - | $-45,000 | - | $-18,386,000 | - |
| 2016 | $0 | - | $0 | - | $-4,625,000 | - |
See TECX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TECX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TECX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTECX — Frequently Asked Questions
Quick answers to the most common questions about buying TECX stock.
Is TECX's revenue growth accelerating or slowing?
TECX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TECX's long-term revenue growth rate?
Tectonic Therapeutic, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TECX's revenue distributed by segment?
TECX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.